Get our best money-saving hacks and pro tips now

ABBV Jan 2025 155.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

14.80

0.00

(0.00%)

As of 02:46PM EST. Market open.

Zacks
AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards?
AbbVie's (ABBV) Q4 performance will likely reflect strong drug demand from its immunology and neuroscience franchises. Investors will also enquire about ABBV's plans to counter Humira LOE.
Simply Wall St.
AbbVie's (NYSE:ABBV) investors will be pleased with their favorable 80% return over the last three years
AbbVie Inc. ( NYSE:ABBV ) shareholders have seen the share price descend 13% over the month. But don't let that...
Motley Fool
2 Stocks Down More Than 6% to Buy Right Now
In fact, two stocks that outperformed the S&P 500 last year are now down more than 6% since the start of the year: Johnson & Johnson (NYSE: JNJ) and AbbVie (NYSE: ABBV).. Motley Fool contributors Adria Cimino and Keith Speights talk about why these two stocks actually make great buys right now. Adria Cimino (Johnson & Johnson): J&J may have disappointed investors when it reported fourth-quarter earnings on Jan. 24.